xml_file stringlengths 5 11 | reference_id stringlengths 1 7 | date_last_updated stringclasses 487
values | pubmed_id stringlengths 5 8 ⌀ | article_year int64 1.95k 2.03k ⌀ | article_title stringlengths 23 347 ⌀ | journal_title stringlengths 3 197 ⌀ | authors stringlengths 5 2.35k ⌀ | epitope_id stringlengths 1 7 ⌀ | epitope_name stringlengths 1 85 ⌀ | epitope_structure_type stringclasses 8
values | epitope_chemical_type stringclasses 18
values | linear_sequence stringlengths 1 829 ⌀ | linear_sequence_length int64 1 829 ⌀ | discontinuous_residues stringlengths 2 419 ⌀ | starting_position int64 0 34.8k ⌀ | ending_position int64 3 34.8k ⌀ | source_organism_id stringlengths 1 8 ⌀ | source_molecule_genbank_id stringlengths 4 14 ⌀ | reference_region stringlengths 2 409 ⌀ | epitope_structure_defines stringclasses 4
values | epitope_evidence_code stringclasses 6
values | assay_category stringclasses 4
values | assay_id stringlengths 2 8 | assay_type_id stringclasses 412
values | assay_location_of_data stringlengths 4 126 ⌀ | qualitative_measurement stringclasses 5
values | is_positive bool 2
classes | quantitative_measurement stringlengths 3 25 ⌀ | host_organism_id stringclasses 729
values | host_sex stringclasses 2
values | host_age stringlengths 1 39 ⌀ | disease_state stringclasses 666
values | mhc_allele_id stringclasses 868
values | mhc_allele_types_present stringlengths 1 150 ⌀ | cell_type stringclasses 41
values | cell_tissue_type stringclasses 49
values | cell_culture_conditions stringclasses 9
values | antigen_evidence_code stringclasses 6
values | immunogen_evidence_code stringclasses 6
values | assay_comments stringclasses 0
values | split_bucket int64 1 9 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537479 | 316 | Figure 1 and S2 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537467 | 263 | Figure S1 | Positive | true | 0.0000325 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537468 | 262 | Figure S1 | Positive | true | 195000.0 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537469 | 263 | Figure S1 | Positive | true | 0.0000855 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537471 | 263 | Figure S1 | Positive | true | 0.000236 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537480 | 316 | Figure 1 and S2 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537483 | 316 | Figures 1, 4, S2 and S13 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537481 | 316 | Figure 1 and S2 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537482 | 316 | Figures 1, 3, 4, S2 and S13 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537514 | 45 | Figure S1 and S5 | Positive | true | 0.488 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537515 | 45 | Figure S1 | Positive | true | 0.637 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537516 | 45 | Figure S1 | Positive | true | 0.913 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537517 | 45 | Figure S1 | Positive | true | 0.438 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537518 | 45 | Figure S1 | Positive | true | 4.89 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537529 | 262 | Figure S1 | Positive | true | 195000.0 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537530 | 263 | Figure S1 | Positive | true | 0.0000855 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537531 | 262 | Figure S1 | Positive | true | 48100.0 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537532 | 263 | Figure S1 | Positive | true | 0.000236 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537544 | 316 | Figures 1, 4, S2 and S13 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537545 | 316 | Figure 1 and S2 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537546 | 316 | Figures 1, 4, S2 and S13 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537547 | 316 | Figure S2 | Positive-Low | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537533 | 262 | Figure S1 | Positive | true | 204000.0 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537534 | 263 | Figure S1 | Positive | true | 0.000891 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537535 | 262 | Figure S1 | Positive | true | 217000.0 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537536 | 263 | Figure S1 | Positive | true | 0.000472 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537537 | 262 | Figure S1 | Positive | true | 70400.0 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537548 | 316 | Figure 1 and S2 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537549 | 316 | Figure 1 and S2 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537550 | 316 | Figure 1 and S2 | Positive-Low | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537551 | 34 | Figure 3 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537552 | 34 | Figure 3 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537553 | 34 | Figure 3 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537556 | 316 | Figure 3 and S10 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537567 | 190 | Figure 6 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537519 | 45 | Figure S1 | Positive | true | 4.38 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537520 | 45 | Figure S1 | Positive | true | 2.17 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537522 | 45 | Figure S1 | Positive-Low | true | 8750.0 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537521 | 45 | Figure S1 | Positive | true | 6.47 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537523 | 262 | Figure S1 | Positive | true | 48400.0 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537538 | 263 | Figure S1 | Positive | true | 0.000455 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537554 | 45 | Figures 3, 4 and S12 | Positive | true | 6.83 | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537563 | 263 | Figures 3, 4 and S12 | Positive | true | 0.000528 | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537555 | 45 | Figures 3, 4 and S12 | Positive | true | 7.24 | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537557 | 45 | Figures 2, 4, S8 and S12 | Positive-Low | true | 1480.0 | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537562 | 262 | Figures 3, 4 and S12 | Positive | true | 77200.0 | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537539 | 316 | Figures 1, 4, S2 and S13 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537564 | 602 | Figure 5 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537565 | 600 | Figure 5 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537566 | 600 | Figure 5 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537513 | 437 | Figures 2, S7, S9, Table S1 and PDB 9KVT | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537524 | 263 | Figure S1 | Positive | true | 0.0000236 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537528 | 263 | Figure S1 | Positive | true | 0.0000325 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537525 | 262 | Figure S1 | Positive | true | 60400.0 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537526 | 263 | Figure S1 | Positive | true | 0.0000385 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537527 | 262 | Figure S1 | Positive | true | 356000.0 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537558 | 262 | Figure 4 and S12 | Positive-Low | true | 84000.0 | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537560 | 262 | Figures 3, 4 and S12 | Positive | true | 165000.0 | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537559 | 263 | Figure 4 and S12 | Positive-Low | true | 0.124 | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537561 | 263 | Figures 3, 4 and S12 | Positive | true | 0.0012 | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537540 | 316 | Figure 1 and S2 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537543 | 316 | Figures 1, 3, 4, S2 and S13 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537541 | 316 | Figure 1 and S2 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454906 | Epitope of Fab 1C4 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, A341, T342, R343, K437, L438, S440, K441, V442, N445, N447, P496 | null | null | 10002875 | URA46263.1 | E340, N343, A344, T345, R346, K440, L441, S443, K444, V445, N448, N450, P499 | Partial Epitope | null | BCell | 28537542 | 316 | Figure 1 and S2 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454904 | Epitope of Fab 8H12 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | L452, F453, Y470, A472, G473, N474, V480, A481, G482, F483, N484, Y486 | null | null | 10002661 | UJU86738.1 | L455, F456, Y473, A475, G476, N477, V483, A484, G485, F486, N487, Y489 | Partial Epitope | null | BCell | 28537778 | 190 | Figure 2 and S8 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 6 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454904 | Epitope of Fab 8H12 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | L452, F453, Y470, A472, G473, N474, V480, A481, G482, F483, N484, Y486 | null | null | 10002661 | UJU86738.1 | L455, F456, Y473, A475, G476, N477, V483, A484, G485, F486, N487, Y489 | Partial Epitope | null | BCell | 28537673 | 316 | Figure 3 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 6 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454904 | Epitope of Fab 8H12 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | L452, F453, Y470, A472, G473, N474, V480, A481, G482, F483, N484, Y486 | null | null | 10002661 | UJU86738.1 | L455, F456, Y473, A475, G476, N477, V483, A484, G485, F486, N487, Y489 | Partial Epitope | null | BCell | 28537684 | 34 | Figure 3 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 6 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454904 | Epitope of Fab 8H12 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | L452, F453, Y470, A472, G473, N474, V480, A481, G482, F483, N484, Y486 | null | null | 10002661 | UJU86738.1 | L455, F456, Y473, A475, G476, N477, V483, A484, G485, F486, N487, Y489 | Partial Epitope | null | BCell | 28537660 | 316 | Figure 3 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 6 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454904 | Epitope of Fab 8H12 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | L452, F453, Y470, A472, G473, N474, V480, A481, G482, F483, N484, Y486 | null | null | 10002661 | UJU86738.1 | L455, F456, Y473, A475, G476, N477, V483, A484, G485, F486, N487, Y489 | Partial Epitope | null | BCell | 28537661 | 316 | Figure 3 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 6 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454904 | Epitope of Fab 8H12 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | L452, F453, Y470, A472, G473, N474, V480, A481, G482, F483, N484, Y486 | null | null | 10002661 | UJU86738.1 | L455, F456, Y473, A475, G476, N477, V483, A484, G485, F486, N487, Y489 | Partial Epitope | null | BCell | 28537662 | 316 | Figure 3 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 6 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454904 | Epitope of Fab 8H12 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | L452, F453, Y470, A472, G473, N474, V480, A481, G482, F483, N484, Y486 | null | null | 10002661 | UJU86738.1 | L455, F456, Y473, A475, G476, N477, V483, A484, G485, F486, N487, Y489 | Partial Epitope | null | BCell | 28537668 | 34 | Figure 3 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 6 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454904 | Epitope of Fab 8H12 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | L452, F453, Y470, A472, G473, N474, V480, A481, G482, F483, N484, Y486 | null | null | 10002661 | UJU86738.1 | L455, F456, Y473, A475, G476, N477, V483, A484, G485, F486, N487, Y489 | Partial Epitope | null | BCell | 28537669 | 34 | Figure 3 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 6 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454904 | Epitope of Fab 8H12 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | L452, F453, Y470, A472, G473, N474, V480, A481, G482, F483, N484, Y486 | null | null | 10002661 | UJU86738.1 | L455, F456, Y473, A475, G476, N477, V483, A484, G485, F486, N487, Y489 | Partial Epitope | null | BCell | 28537670 | 34 | Figures 2, 3 and S8 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 6 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454904 | Epitope of Fab 8H12 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | L452, F453, Y470, A472, G473, N474, V480, A481, G482, F483, N484, Y486 | null | null | 10002661 | UJU86738.1 | L455, F456, Y473, A475, G476, N477, V483, A484, G485, F486, N487, Y489 | Partial Epitope | null | BCell | 28537630 | 437 | Figures 2, S7, S9, Table S1 and PDB 9KVQ | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 6 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454908 | Epitope of Fab 8H12 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | L452, F453, Y470, A472, G473, N474, K475, V480, A481, G482, F483, N484, Y486 | null | null | 10002875 | URA46263.1 | L455, F456, Y473, A475, G476, N477, K478, V483, A484, G485, F486, N487, Y489 | Partial Epitope | null | BCell | 28537779 | 190 | Figure 2 and S8 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454908 | Epitope of Fab 8H12 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | L452, F453, Y470, A472, G473, N474, K475, V480, A481, G482, F483, N484, Y486 | null | null | 10002875 | URA46263.1 | L455, F456, Y473, A475, G476, N477, K478, V483, A484, G485, F486, N487, Y489 | Partial Epitope | null | BCell | 28537686 | 437 | Figures 2, S7, S9, Table S1 and PDB 9KVT | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454908 | Epitope of Fab 8H12 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | L452, F453, Y470, A472, G473, N474, K475, V480, A481, G482, F483, N484, Y486 | null | null | 10002875 | URA46263.1 | L455, F456, Y473, A475, G476, N477, K478, V483, A484, G485, F486, N487, Y489 | Partial Epitope | null | BCell | 28537716 | 316 | Figure 3 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454908 | Epitope of Fab 8H12 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | L452, F453, Y470, A472, G473, N474, K475, V480, A481, G482, F483, N484, Y486 | null | null | 10002875 | URA46263.1 | L455, F456, Y473, A475, G476, N477, K478, V483, A484, G485, F486, N487, Y489 | Partial Epitope | null | BCell | 28537717 | 316 | Figure 3 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454908 | Epitope of Fab 8H12 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | L452, F453, Y470, A472, G473, N474, K475, V480, A481, G482, F483, N484, Y486 | null | null | 10002875 | URA46263.1 | L455, F456, Y473, A475, G476, N477, K478, V483, A484, G485, F486, N487, Y489 | Partial Epitope | null | BCell | 28537718 | 316 | Figure 3 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454908 | Epitope of Fab 8H12 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | L452, F453, Y470, A472, G473, N474, K475, V480, A481, G482, F483, N484, Y486 | null | null | 10002875 | URA46263.1 | L455, F456, Y473, A475, G476, N477, K478, V483, A484, G485, F486, N487, Y489 | Partial Epitope | null | BCell | 28537729 | 316 | Figure 3 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454908 | Epitope of Fab 8H12 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | L452, F453, Y470, A472, G473, N474, K475, V480, A481, G482, F483, N484, Y486 | null | null | 10002875 | URA46263.1 | L455, F456, Y473, A475, G476, N477, K478, V483, A484, G485, F486, N487, Y489 | Partial Epitope | null | BCell | 28537724 | 34 | Figure 3 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454908 | Epitope of Fab 8H12 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | L452, F453, Y470, A472, G473, N474, K475, V480, A481, G482, F483, N484, Y486 | null | null | 10002875 | URA46263.1 | L455, F456, Y473, A475, G476, N477, K478, V483, A484, G485, F486, N487, Y489 | Partial Epitope | null | BCell | 28537725 | 34 | Figure 3 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454908 | Epitope of Fab 8H12 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | L452, F453, Y470, A472, G473, N474, K475, V480, A481, G482, F483, N484, Y486 | null | null | 10002875 | URA46263.1 | L455, F456, Y473, A475, G476, N477, K478, V483, A484, G485, F486, N487, Y489 | Partial Epitope | null | BCell | 28537726 | 34 | Figures 2, 3 and S8 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454908 | Epitope of Fab 8H12 on SARS-CoV-2 BA.2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | L452, F453, Y470, A472, G473, N474, K475, V480, A481, G482, F483, N484, Y486 | null | null | 10002875 | URA46263.1 | L455, F456, Y473, A475, G476, N477, K478, V483, A484, G485, F486, N487, Y489 | Partial Epitope | null | BCell | 28537740 | 34 | Figure 3 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 5 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454899 | Epitope of Fab 3E2 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | A372, S375, G404, D405, R408, N437, Q498, T500, N501, G502, V503, G504, Y505, Y508 | null | null | 2697049 | P0DTC2.1 | A372, S375, G404, D405, R408, N437, Q498, T500, N501, G502, V503, G504, Y505, Y508 | Partial Epitope | null | BCell | 28537747 | 316 | Figure 3 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454899 | Epitope of Fab 3E2 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | A372, S375, G404, D405, R408, N437, Q498, T500, N501, G502, V503, G504, Y505, Y508 | null | null | 2697049 | P0DTC2.1 | A372, S375, G404, D405, R408, N437, Q498, T500, N501, G502, V503, G504, Y505, Y508 | Partial Epitope | null | BCell | 28537748 | 316 | Figure 3 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454899 | Epitope of Fab 3E2 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | A372, S375, G404, D405, R408, N437, Q498, T500, N501, G502, V503, G504, Y505, Y508 | null | null | 2697049 | P0DTC2.1 | A372, S375, G404, D405, R408, N437, Q498, T500, N501, G502, V503, G504, Y505, Y508 | Partial Epitope | null | BCell | 28537749 | 316 | Figure 3 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454899 | Epitope of Fab 3E2 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | A372, S375, G404, D405, R408, N437, Q498, T500, N501, G502, V503, G504, Y505, Y508 | null | null | 2697049 | P0DTC2.1 | A372, S375, G404, D405, R408, N437, Q498, T500, N501, G502, V503, G504, Y505, Y508 | Partial Epitope | null | BCell | 28537750 | 34 | Figure 3 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454899 | Epitope of Fab 3E2 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | A372, S375, G404, D405, R408, N437, Q498, T500, N501, G502, V503, G504, Y505, Y508 | null | null | 2697049 | P0DTC2.1 | A372, S375, G404, D405, R408, N437, Q498, T500, N501, G502, V503, G504, Y505, Y508 | Partial Epitope | null | BCell | 28537752 | 34 | Figure 2 and S8 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454899 | Epitope of Fab 3E2 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | A372, S375, G404, D405, R408, N437, Q498, T500, N501, G502, V503, G504, Y505, Y508 | null | null | 2697049 | P0DTC2.1 | A372, S375, G404, D405, R408, N437, Q498, T500, N501, G502, V503, G504, Y505, Y508 | Partial Epitope | null | BCell | 28537753 | 316 | Figure 3 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454899 | Epitope of Fab 3E2 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | A372, S375, G404, D405, R408, N437, Q498, T500, N501, G502, V503, G504, Y505, Y508 | null | null | 2697049 | P0DTC2.1 | A372, S375, G404, D405, R408, N437, Q498, T500, N501, G502, V503, G504, Y505, Y508 | Partial Epitope | null | BCell | 28537754 | 34 | Figure 3 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454899 | Epitope of Fab 3E2 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | A372, S375, G404, D405, R408, N437, Q498, T500, N501, G502, V503, G504, Y505, Y508 | null | null | 2697049 | P0DTC2.1 | A372, S375, G404, D405, R408, N437, Q498, T500, N501, G502, V503, G504, Y505, Y508 | Partial Epitope | null | BCell | 28537746 | 437 | Figures 2, S7, Table S1 and PDB 9KVK | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454899 | Epitope of Fab 3E2 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | A372, S375, G404, D405, R408, N437, Q498, T500, N501, G502, V503, G504, Y505, Y508 | null | null | 2697049 | P0DTC2.1 | A372, S375, G404, D405, R408, N437, Q498, T500, N501, G502, V503, G504, Y505, Y508 | Partial Epitope | null | BCell | 28537780 | 190 | Figure 2 and S8 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454902 | Epitope of Fab 3E2 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | A369, P370, F372, G401, D402, R405, N434, T497, Y498, G499, V500, G501, H502, Q503, Y505 | null | null | 10002661 | UJU86738.1 | A372, P373, F375, G404, D405, R408, N437, T500, Y501, G502, V503, G504, H505, Q506, Y508 | Partial Epitope | null | BCell | 28537755 | 437 | Figures 2, S7, S9, Table S1 and PDB 9KVQ | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 3 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454902 | Epitope of Fab 3E2 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | A369, P370, F372, G401, D402, R405, N434, T497, Y498, G499, V500, G501, H502, Q503, Y505 | null | null | 10002661 | UJU86738.1 | A372, P373, F375, G404, D405, R408, N437, T500, Y501, G502, V503, G504, H505, Q506, Y508 | Partial Epitope | null | BCell | 28537756 | 316 | Figure 3 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 3 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454902 | Epitope of Fab 3E2 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | A369, P370, F372, G401, D402, R405, N434, T497, Y498, G499, V500, G501, H502, Q503, Y505 | null | null | 10002661 | UJU86738.1 | A372, P373, F375, G404, D405, R408, N437, T500, Y501, G502, V503, G504, H505, Q506, Y508 | Partial Epitope | null | BCell | 28537757 | 316 | Figure 3 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 3 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454902 | Epitope of Fab 3E2 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | A369, P370, F372, G401, D402, R405, N434, T497, Y498, G499, V500, G501, H502, Q503, Y505 | null | null | 10002661 | UJU86738.1 | A372, P373, F375, G404, D405, R408, N437, T500, Y501, G502, V503, G504, H505, Q506, Y508 | Partial Epitope | null | BCell | 28537758 | 316 | Figure 3 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 3 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454902 | Epitope of Fab 3E2 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | A369, P370, F372, G401, D402, R405, N434, T497, Y498, G499, V500, G501, H502, Q503, Y505 | null | null | 10002661 | UJU86738.1 | A372, P373, F375, G404, D405, R408, N437, T500, Y501, G502, V503, G504, H505, Q506, Y508 | Partial Epitope | null | BCell | 28537759 | 34 | Figure 3 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 3 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454902 | Epitope of Fab 3E2 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | A369, P370, F372, G401, D402, R405, N434, T497, Y498, G499, V500, G501, H502, Q503, Y505 | null | null | 10002661 | UJU86738.1 | A372, P373, F375, G404, D405, R408, N437, T500, Y501, G502, V503, G504, H505, Q506, Y508 | Partial Epitope | null | BCell | 28537761 | 34 | Figure 2 and S8 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 3 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454902 | Epitope of Fab 3E2 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | A369, P370, F372, G401, D402, R405, N434, T497, Y498, G499, V500, G501, H502, Q503, Y505 | null | null | 10002661 | UJU86738.1 | A372, P373, F375, G404, D405, R408, N437, T500, Y501, G502, V503, G504, H505, Q506, Y508 | Partial Epitope | null | BCell | 28537762 | 316 | Figure 3 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 3 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.